Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 42.55
+1.55 (3.78%)
At close: Jun 2, 2026
Sheel Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,100 | 1,018 | 922.82 | 801.16 | 707.36 |
Other Revenue | 7.13 | - | - | - | - |
| 1,107 | 1,018 | 922.82 | 801.16 | 707.36 | |
Revenue Growth (YoY) | 8.83% | 10.26% | 15.19% | 13.26% | 12.23% |
Cost of Revenue | 679.5 | 657.16 | 576.22 | 541.43 | 478.27 |
Gross Profit | 427.85 | 360.37 | 346.6 | 259.73 | 229.09 |
Selling, General & Admin | 147.27 | 149.06 | 137.99 | 106.37 | 94.22 |
Other Operating Expenses | 110.62 | 60.82 | 63.26 | 65.02 | 70.17 |
Operating Expenses | 268.55 | 218.88 | 211.11 | 181.56 | 173.79 |
Operating Income | 159.3 | 141.49 | 135.49 | 78.17 | 55.3 |
Interest Expense | -19.15 | -14.46 | -11.5 | -11.17 | -9 |
Interest & Investment Income | - | 0.78 | 0.76 | 0.57 | 3.01 |
Currency Exchange Gain (Loss) | - | 0.47 | 1.06 | 0.17 | 0.29 |
Other Non Operating Income (Expenses) | 0 | -3.05 | -3.29 | -4.04 | -1.08 |
EBT Excluding Unusual Items | 140.16 | 125.23 | 122.52 | 63.7 | 48.53 |
Gain (Loss) on Sale of Investments | - | 1.88 | - | - | - |
Gain (Loss) on Sale of Assets | - | 1.13 | - | - | - |
Pretax Income | 140.16 | 128.23 | 122.52 | 63.7 | 48.53 |
Income Tax Expense | 22.6 | 21.87 | 17.78 | 12.93 | -0.04 |
Net Income | 117.56 | 106.36 | 104.75 | 50.77 | 48.57 |
Net Income to Common | 117.56 | 106.36 | 104.75 | 50.77 | 48.57 |
Net Income Growth | 10.53% | 1.54% | 106.34% | 4.52% | 20.48% |
Shares Outstanding (Basic) | 18 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 18 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | 19.13% | 1.71% | - | - | 250.00% |
EPS (Basic) | 6.69 | 7.21 | 7.22 | 3.50 | 3.35 |
EPS (Diluted) | 6.69 | 7.21 | 7.22 | 3.50 | 3.35 |
EPS Growth | -7.21% | -0.14% | 106.29% | 4.51% | -65.58% |
Free Cash Flow | -242.28 | 79.7 | -12.14 | 81.38 | 9.81 |
Free Cash Flow Per Share | -13.79 | 5.40 | -0.84 | 5.61 | 0.68 |
Dividend Per Share | - | - | 1.000 | 3.100 | 0.886 |
Dividend Growth | - | - | -67.74% | 250.01% | - |
Gross Margin | 38.64% | 35.42% | 37.56% | 32.42% | 32.39% |
Operating Margin | 14.39% | 13.91% | 14.68% | 9.76% | 7.82% |
Profit Margin | 10.62% | 10.45% | 11.35% | 6.34% | 6.87% |
Free Cash Flow Margin | -21.88% | 7.83% | -1.31% | 10.16% | 1.39% |
EBITDA | 169.96 | 150.49 | 145.36 | 88.34 | 64.7 |
EBITDA Margin | 15.35% | 14.79% | 15.75% | 11.03% | 9.15% |
D&A For EBITDA | 10.66 | 9 | 9.87 | 10.17 | 9.4 |
EBIT | 159.3 | 141.49 | 135.49 | 78.17 | 55.3 |
EBIT Margin | 14.39% | 13.91% | 14.68% | 9.76% | 7.82% |
Effective Tax Rate | 16.12% | 17.06% | 14.51% | 20.30% | - |
Revenue as Reported | 1,107 | 1,023 | 925.46 | 801.94 | 710.66 |
Advertising Expenses | - | 4.44 | 4.11 | 1.49 | 1.75 |